Hong Kong Island, Hong Kong, China | Fund Name | Location |
| Astorg | France, Ile-de-France, Paris |
| Caitong Securities | China, Hangzhou, Zhejiang |
| Coronis Medical Ventures | California, Sunnyvale, United States |
| Future Money | Seoul, Seoul-t'ukpyolsi, South Korea |
| GENTOSHA MediaConsulting | Japan, Tokyo |
| Harbinger Capital Partners | New York, New York, United States |
| InMotion Ventures | England, London, United Kingdom |
| ION Crossover Partners | Israel, Tel Aviv, Tel Aviv District |
| Razor Capital | England, London, United Kingdom |
| Rocket Ventures | Ohio, Toledo, United States |
| Rongxin Zhitong | Beijing, Beijing Shi, China |
| Social Capital Hedosophia | California, Palo Alto, United States |
| Source Interlink Companies | Bonita Springs, Florida, United States |
| Tekelec International | Morrisville, North Carolina, United States |
| United Finsec | - |
| venture / science | California, San Francisco, United States |
| Wuhan Optics Valley Elite Investment Management | China, Hubei, Wuhan |
| Xinyu Tongrong Gongxing Touzi | China, Jiangxi, Xinyu |
| Zhi Xin Qiye Guanli | China, Shaanxi, Xian Shi |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
ASLAN Pharmaceuticals | $34M | 07 Dec 2015 | Singapore, Central Region, Singapore |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
ASLAN Pharmaceuticals | $34M | 07 Dec 2015 | Singapore, Central Region, Singapore |
